Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Semi Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel pleuromutilin derivatives with thiazole-pyridine side chains offer superior antibacterial activity against resistant strains, featuring a scalable three-step synthesis.
Patent CN113956224B details novel hesperetin derivatives with enhanced bioavailability. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN1158126A reveals a novel oxazolidine coupling method for paclitaxel. Enhances yield and stereocontrol for reliable API intermediate supply chains.
Patent CN1942458A details novel semi-synthesis of taxane intermediates from cephalomannine. Offers cost reduction in API manufacturing and enhanced supply chain reliability for paclitaxel production.
Patent CN1942460A enables efficient one-pot taxane semi-synthesis reducing steps and costs for reliable API intermediate supply chains globally.
Patent CN101020676A reveals a high-yield semi-synthesis route for Taxol and Docetaxel, offering cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Patent CN103172645A details a scalable route from artemisinic acid. Offers high yield and purity for API intermediates. Ideal for pharmaceutical supply chains.
Advanced synthesis of benzoyl acrylic podophyllotoxin esters via patent CN113185529B offers reduced toxicity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Novel water-avoidance method improves purity and yield for furbenicillin acid manufacturing ensuring reliable supply chain and significant cost reduction for global buyers
Advanced semi-synthesis of Docetaxel using novel oxazoline side chains. Reduces acyl migration risks and offers cost-effective scaling for pharmaceutical manufacturers.
Patent CN104804021A details high-mobility n-type organic semiconductors. Discover cost-effective, solution-processable materials for flexible electronics and supply chain optimization.
Explore the novel synthesis of potent antitumor 23-heteroatom OSW-1 analogues via efficient aldol reactions and glycosylation, offering reliable supply chain solutions.
Novel semi-synthetic route for 7-silylcamptothecin via radical silylation. Enhances supply chain stability and reduces manufacturing costs for anticancer intermediates.
Patent CN107141272A reveals high-yield docetaxel synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN107235971B details Retapamulin synthesis from Tiamulin. Offers better impurity control and cost reduction for API manufacturers and supply chains.
Patent CN107235971A reveals a novel Tiamulin-based route for Retapamulin. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1080256C discloses crystalline beta-lactam intermediates enabling high-yield paclitaxel production with superior stereochemical control and simplified purification processes.
Novel CN108264529A route for Tildipirosin reduces steps and waste. Ideal for reliable veterinary drug supplier seeking cost reduction in macrolide manufacturing.
Patent CN1724554A details a streamlined 5-step synthesis for 1,4-pregnadiene-17α,21-dihydroxy-3,20-dione-17α,21-diacetate, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN104109142A details cabazitaxel production from baccatin III. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.